| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 03/20/2013 | CN102977041A Preparation method of mequindox metabolic product desoxymequindox |
| 03/20/2013 | CN102977040A Method for synthesizing 2-quinoxalinyl dimethylacetal and 2-quinoxalinyl formaldehyde |
| 03/20/2013 | CN102977039A Alpha crystal form of 6-fluo-3-hydroxyl-2-pyrazinecarboxamide and preparation method thereof |
| 03/20/2013 | CN102977038A Bis(2-acetylpyrazine) thiocarbonohydrazone and preparation method and application of bismuth (III) complex thereof |
| 03/20/2013 | CN102977037A Separation method of pyrazine and ethylenediamine mixture |
| 03/20/2013 | CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs |
| 03/19/2013 | US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
| 03/14/2013 | WO2013035102A1 Processes for the preparation of imatinib base and intermediates thereof |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
| 03/14/2013 | US20130065900 Pharmaceutical compounds |
| 03/14/2013 | US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 03/14/2013 | US20130064871 Composition comprising a dibenzoylmethane screening agent and a merocyanine dicyano or cyanoacetate derivative; method for the photostabilization of the dibenzoylmethane screening agent |
| 03/13/2013 | EP2566847A1 Novel immunomodulator and anti inflammatory compounds |
| 03/13/2013 | CN101563329B Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione) |
| 03/12/2013 | US8394954 Benzophenone hybrids as anticancer agents and processes for the preparation thereof |
| 03/12/2013 | US8394806 2-phenyl pyrazines as tubulin inhibitors |
| 03/12/2013 | US8394805 Compounds |
| 03/12/2013 | US8394804 Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2695088C Novel piperazine amide derivatives |
| 03/07/2013 | WO2013032874A1 Improved process for making alkoxylated piperazine compounds |
| 03/07/2013 | US20130060034 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity |
| 03/07/2013 | US20130060033 Light-emitting element, light-emitting device, electronic device, lighting device, and heterocyclic compound |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/06/2013 | EP2566302A1 Organometallic compounds and emission-shifting organic electrophosphorence |
| 03/06/2013 | EP2565183A1 Glycine transporter-1 inhibitors |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/06/2013 | CN102952088A Preparation method of dexrazoxane |
| 03/06/2013 | CN102952080A Benzoheterocycle contained ether compound and its use |
| 03/05/2013 | US8389734 Amides useful as inhibitors of voltage-gated sodium channels |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389533 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
| 03/05/2013 | US8389470 Methods and compositions for delivering peptides |
| 02/28/2013 | US20130053392 Carbonic anhydrase inhibitors |
| 02/28/2013 | US20130053384 Certain Chemical Entities, Compositions, and Methods |
| 02/28/2013 | US20130052585 Photodecomposable bases and photoresist compositions |
| 02/27/2013 | EP2562168A1 Therapeutic piperazines as PDE4 inhibitors |
| 02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 02/27/2013 | EP2560963A1 Derivatives of nitrogen heterocycles, method for preparing same and use thereof in human therapy |
| 02/27/2013 | CN102942530A Novel anti-tumor compound and medication composition thereof |
| 02/27/2013 | CN102942429A Method for preparing aza or thia aryl biaryl compound by aid of palladium and carbon catalysts |
| 02/27/2013 | CN102206188B Preparation method for N-(pyrazine-2-yl carbonyl)-L-phenylalanine |
| 02/27/2013 | CN101417982B Synthesis of 4-ethyl-(2,3-dioxo piperazinyl)formyl chloride-1 and preparation of crystal thereof |
| 02/26/2013 | US8383653 SIR2 regulation |
| 02/26/2013 | US8383629 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
| 02/26/2013 | CA2534682C Capped pyrazinoylguanidine sodium channel blockers |
| 02/21/2013 | US20130045972 Glucocorticoid receptor antagonists |
| 02/21/2013 | US20130045499 Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles |
| 02/20/2013 | CN101351451B Multicyclic amino acid derivatives and methods of their use |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8378095 Oxazole tyrosine kinase inhibitors |
| 02/19/2013 | US8377935 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| 02/19/2013 | US8377923 Triazole derivative or salt thereof |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/14/2013 | WO2013021276A1 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 02/14/2013 | US20130040949 Type ii raf kinase inhibitors |
| 02/14/2013 | US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/13/2013 | EP2556039A1 Fluorinating reagents with (perfluoralkyl) fluorophosphate anion |
| 02/13/2013 | CN102933549A Process for preparing a cyclic tertiary methylamine |
| 02/13/2013 | CN102924389A Preparation method of 5-methylpyrazinyl-2-carboxylic acid |
| 02/13/2013 | CN102924388A Pyrazine compound and preparation method thereof |
| 02/12/2013 | CA2708502C Perhydroquinoxaline derivatives |
| 02/12/2013 | CA2498936C Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 02/07/2013 | WO2012111579A9 Light-emitting element |
| 02/07/2013 | US20130035487 Bioavailable Diacylhydrazine Ligands for Modulations the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/07/2013 | US20130035328 Antiviral compounds and methods |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130035296 Therapeutic peptides |
| 02/06/2013 | EP2554540A2 3-Cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 02/06/2013 | CN101395106B Dibenzoanthracene compound and organic light emitting device having the same |
| 02/05/2013 | US8367844 Microbiocidal heterocycles |
| 02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
| 02/05/2013 | US8367672 Pyridazine compounds, compositions and methods |
| 02/05/2013 | CA2684404C Novel piperazine salts as d3/d2 antagonists |
| 01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
| 01/31/2013 | US20130030003 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof |
| 01/30/2013 | CN102898388A Method for synthesizing substituted benzo[alpha]phenazine compound |
| 01/30/2013 | CN102898387A Channelized method for continuously producing N-[(2Z)-piperazine-2-subunit]-2, 2, 2-trifluoroacetyl hydrazine |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362242 Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/29/2013 | US8361426 Absorption medium and method for removing sour gases from fluid streams, in particular from flue gases |
| 01/29/2013 | CA2672860C Inhibitors of poly(adp-ribose)polymerase |
| 01/24/2013 | WO2012135025A3 Conjugated lipomers and uses thereof |
| 01/24/2013 | WO2012109256A3 Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine |
| 01/24/2013 | US20130019949 Compounds for organic thin-film solar cells and organic thin-film solar cells |
| 01/23/2013 | EP2548874A2 Substituted piperazines as CB1 antagonists |
| 01/23/2013 | EP2547656A1 Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102892758A Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102887863A Dioxoquinoxaline formamidourea with plant growth regulating activity, preparation method and application thereof |
| 01/23/2013 | CN101490017B Therapeutic piperazines as pde4 inhibitors |
| 01/22/2013 | US8357685 Substituted diketopiperazines and their use as oxytocin antagonists |
| 01/22/2013 | US8357679 Hexafluoroisopropanol derivatives |
| 01/22/2013 | CA2464451C Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 01/17/2013 | WO2013007371A2 Kinetic resolution of chiral amines |
| 01/17/2013 | US20130018044 New inhibitors of cyclophilins and uses thereof |
| 01/16/2013 | CN102875482A Method for synthesizing decahydroquinoxaline |
| 01/16/2013 | CN101610772B Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
| 01/15/2013 | US8354536 Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides |